President Donald Trump said his administration would “deploy every tool” to get drug prices reduced from large pharmaceutical ...

Investors were clearly impressed by the company's second-quarter beats, especially the one on the bottom line.

It also heralded a change in strategy, with CEO Robert Davis saying that the company is undergoing "a multiyear optimization ...

The S&P 500 slipped 0.4% on Thursday, July 31, 2025, as investors reacted to higher-than-expected inflation data while ...

The 15 percent tariff rate agreed under the new deal could significantly impact pharma firms reliant on European imports.

CRUDE AWAKENING Part 2 In a world constantly in motion, where ambition shapes empires and innovation fuels the future, there exists a silent force, unseen yet omnipresent. […] ...

The Trump administration has pledged to curb rising obesity with school meal reforms and artificial dye bans, though the ...

From detecting fraud to curing disease, agentic AI isn’t just smart — it’s rewriting the rules of how entire industries work.

Trump’s EU trade deal exposes the media’s April tariff freakout—predictions of empty shelves, recession, and market collapse ...

President Donald Trump called out 17 Big Pharma CEOs over "exorbitant" drug pricing in individual letters sent out Thursday, ...

This regulatory relief, combined with several other compelling catalysts, creates a pathway for the stock to potentially ...

West Pharmaceutical Services, Inc.'s Q2 results highlight growth driven by GLP-1 drugs and high-value products. Click for WST ...